iCell Cardiomyocytes

Scientific Advisory Board

Scientific Advisory Board
Members of CDI's SAB, from left: George Church, James Thomson, and Lee Hood

George Church, PhD
Professor of Genetics Harvard Medical School
Director of the Center for Computational Genetics

Dr. George Church is professor of genetics at Harvard Medical School; director of the Lipper Center for Computational Genetics, DOE Genomes to Life Center, NIH Center for Excellence in Genomic Science, and the Personal Genome Project; as well as member of the Wyss Institute and Broad Institute. He pioneered the first direct genomic sequencing method, which led to the first commercial genome sequence, and to second-generation sequencing – e.g. open-source Polonator.org. Dr. Church has 34 patents including molecular multiplexing and tags, homologous recombination methods, and DNA array synthesizers. He has advised 24 companies, including founding LS9, JouleBio, and Knome.

James A. Thomson, VMD, PhD
Chief Scientific Officer

Dr. Thomson is one of our founders and has served as our Chief Scientific Officer and as a member of our board of directors since 2007. He received a VMD and a Ph.D. from the University of Pennsylvania. He is a member of the National Academy of Sciences, and has served as the Director of Regenerative Biology at the Morgridge Institute for Research since 2008 and as the John D. MacArthur Professor of Anatomy at the University of Wisconsin-Madison since 2003. Dr. Thomson’s derivation of human ES cells was featured as Science Magazine’s “Scientific Breakthrough of the year” in 1999, and work from Dr. Thomson’s laboratory has been cited in TIME Magazine's “Top 10 Discoveries of the Year” on three separate occasions, including the isolation of human ES cells (1998, #1), the isolation of human iPS cells (2007, #1) and the collaborative mapping of the human epigenome (2009, #2). He was featured on the cover of TIME Magazine’s “America’s Best in Science and Medicine” in 2001, and in 2007 was named one of TIME Magazine’s “100 Most Influential People in the World.” Dr. Thomson has published over 150 scientific, peer-reviewed papers and has been an inventor on 30 issued patents. We selected Dr. Thomson to serve on our board of directors due to his understanding of our business and his seminal work and international recognition in the stem cell field.

Lee Hood, MD, PhD
President, Institute for Systems Biology
Affiliate Professor, Immunology
University of Washington

Dr. Hood is a pioneer in the systems approach to biology and medicine. His research has focused on the study of molecular immunology, biotechnology and genomics. Dr. Hood’s professional career began at Caltech, where he and his colleagues developed the DNA gene sequencer and synthesizer and the protein synthesizer and sequencer––four instruments that paved the way for the successful mapping of the human genome. A pillar in the biotechnology field, Dr. Hood has played a role in founding more than fourteen biotechnology companies, including Amgen, Applied Biosystems, Darwin, The Accelerator and Integrated Diagnostics. He is a member of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. Of the 6,000+ scientists world-wide who belong to one or more of these academies, Dr. Hood is one of only fifteen people accepted to all three. He is also a member of the American Philosophical Society and a Fellow of the American Academy of Arts and Sciences. His work has been widely published, and he has coauthored numerous textbooks in biochemistry, immunology, molecular biology and genetics, as well as a popular book on the human genome project, The Code of Codes. He is the recipient of numerous awards, including the Lasker Award for Studies of Immune Diversity, the Kyoto Prize in advanced technology, the Heinz Award for pioneering work in Systems Biology, and most recently, the coveted NAE 2011 Fritz J. and Delores H. Russ Prize for automating DNA sequencing that revolutionized biomedicine and forensic science. In addition to having received 17 honorary degrees from prestigious universities in the US and abroad, Dr. Hood has published more than 700 peer reviewed articles and currently holds 36 patents.